Computed tomography–based pericoronary adipose tissue attenuation in patients undergoing TAVR: a novel method for risk assessment

Steyer A, Mas-Peiro S, Leistner DM, Puntmann VO, Nagel E, Dey D, Göller M, Koch V, Booz C, Vogl TJ, Martin SS (2023)

Publication Type: Journal article

Publication year: 2023

Journal

Frontiers in Cardiovascular Medicine Frontiers Media

Book Volume: 10

Article Number: 1192093

DOI: 10.3389/fcvm.2023.1192093

Abstract

Objectives: This study aims to assess the attenuation of pericoronary adipose tissue (PCAT) surrounding the proximal right coronary artery (RCA) in patients with aortic stenosis (AS) and undergoing transcatheter aortic valve replacement (TAVR). RCA PCAT attenuation is a novel computed tomography (CT)–based marker for evaluating coronary inflammation. Coronary artery disease (CAD) in TAVR patients is common and usually evaluated prior to intervention. The most sensible screening method and consequential treatment approach are unclear and remain a matter of ceaseless discussion. Thus, interest remains for safe and low-demand predictive markers to identify patients at risk for adverse outcomes postaortic valve replacement. Methods: This single-center retrospective study included patients receiving a standard planning CT scan prior to TAVR. Conventional CAD diagnostic tools, such as coronary artery calcium score and significant stenosis via invasive coronary angiography and coronary computed tomography angiography, were determined in addition to RCA PCAT attenuation using semiautomated software. These were assessed for their relationship with major adverse cardiovascular events (MACE) during a 24-month follow-up period. Results: From a total of 62 patients (mean age: 82 ± 6.7 years), 15 (24.2%) patients experienced an event within the observation period, 10 of which were attributed to cardiovascular death. The mean RCA PCAT attenuation was higher in patients enduring MACE than that in those without an endpoint (−69.8 ± 7.5 vs. −74.6 ± 6.2, P = 0.02). Using a predefined cutoff of >−70.5 HU, 20 patients (32.3%) with high RCA PCAT attenuation were identified, nine (45%) of which met the endpoint within 2 years after TAVR. In a multivariate Cox regression model including conventional CAD diagnostic tools, RCA PCAT attenuation prevailed as the only marker with significant association with MACE (P = 0.02). After dichotomization of patients into high- and low-RCA PCAT attenuation groups, high attenuation was related to greater risk of MACE (hazard ration: 3.82, P = 0.011). Conclusion: RCA PCAT attenuation appears to have predictive value also in a setting of concomitant AS in patients receiving TAVR. RCA PCAT attenuation was more reliable than conventional CAD diagnostic tools in identifying patients at risk for MACE.

Authors with CRIS profile

Markus Göller Department of Medicine 2 – Cardiology and Angiology

Involved external institutions

Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Cedars-Sinai Medical Center US United States (USA) (US)

How to cite

APA:

Steyer, A., Mas-Peiro, S., Leistner, D.M., Puntmann, V.O., Nagel, E., Dey, D.,... Martin, S.S. (2023). Computed tomography–based pericoronary adipose tissue attenuation in patients undergoing TAVR: a novel method for risk assessment. Frontiers in Cardiovascular Medicine, 10. https://dx.doi.org/10.3389/fcvm.2023.1192093

MLA:

Steyer, Alexandra, et al. "Computed tomography–based pericoronary adipose tissue attenuation in patients undergoing TAVR: a novel method for risk assessment." Frontiers in Cardiovascular Medicine 10 (2023).

BibTeX: Download